Indication
EGFR exon 18 G719X and exon 21 L861Q mutations
1 clinical trial
3 products
Product
CarboplatinClinical trial
Phase I/II Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsStatus: Active (not recruiting), Estimated PCD: 2024-08-23
Product
PemetrexedProduct
BLU-451